New Guideline Gives Active Surveillance a Boost
The 2022 guidance for the first time makes active surveillance the recommended treatment for select patients with favorable intermediate-risk Gleason 3+4 prostate cancer.
Source: medscape.com
James Schraidt News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from James Schraidt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In James Schraidt Today - Breaking & Trending Today